A European survey on donor deferral for allergy: Rationale and initial results of a survey in 35 countries

O Garraud; C Martin; A Haddad; M Bagge Hansen; G Rautmann; S MacLennan; R Norda

doi:10.1016/j.tracli.2016.12.001

A European survey on donor deferral for allergy: Rationale and initial results of a survey in 35 countries

O Garraud, C Martin, A Haddad, M Bagge Hansen, G Rautmann, S MacLennan, R Norda

Department of Clinical Medicine

Abstract

Allergy accounts to near 0.5% of all reported transfusion adverse events. The responsibility of blood components themselves and - therefore - of blood donors is still questioned. The European Community undertook a large international survey to address the consistency and homogeneity of medical selection of blood donors with regard to the risk of allergy, and especially of transferring allergy to recipients. This short report presents the salient points of the survey, stressing that there is inconsistency in addressing the allergy question within countries or systems, with paths of improvement.

Original language	English
Journal	Transfusion Clinique et Biologique
Volume	24
Issue number	1
Pages (from-to)	34-35
ISSN	1246-7820
DOIs	https://doi.org/10.1016/j.tracli.2016.12.001
Publication status	Published - 1 Feb 2017

Keywords

Anti-Allergic Agents/blood
Blood Donors
Donor Selection/standards
Drug Hypersensitivity/blood
Europe/epidemiology
Health Care Surveys
Health Policy
Humans
Hypersensitivity/blood
Surveys and Questionnaires
Transfusion Reaction/prevention & control

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.tracli.2016.12.001

Cite this

@article{b1dfe076ed0844ba8626b1cbd59635d8,

title = "A European survey on donor deferral for allergy: Rationale and initial results of a survey in 35 countries",

abstract = "Allergy accounts to near 0.5% of all reported transfusion adverse events. The responsibility of blood components themselves and - therefore - of blood donors is still questioned. The European Community undertook a large international survey to address the consistency and homogeneity of medical selection of blood donors with regard to the risk of allergy, and especially of transferring allergy to recipients. This short report presents the salient points of the survey, stressing that there is inconsistency in addressing the allergy question within countries or systems, with paths of improvement.",

keywords = "Anti-Allergic Agents/blood, Blood Donors, Donor Selection/standards, Drug Hypersensitivity/blood, Europe/epidemiology, Health Care Surveys, Health Policy, Humans, Hypersensitivity/blood, Surveys and Questionnaires, Transfusion Reaction/prevention & control",

author = "O Garraud and C Martin and A Haddad and {Bagge Hansen}, M and G Rautmann and S MacLennan and R Norda",

year = "2017",

month = feb,

day = "1",

doi = "10.1016/j.tracli.2016.12.001",

language = "English",

volume = "24",

pages = "34--35",

journal = "Transfusion Clinique et Biologique",

issn = "1246-7820",

publisher = "Elsevier Masson",

number = "1",

}

TY - JOUR

T1 - A European survey on donor deferral for allergy

T2 - Rationale and initial results of a survey in 35 countries

AU - Garraud, O

AU - Martin, C

AU - Haddad, A

AU - Bagge Hansen, M

AU - Rautmann, G

AU - MacLennan, S

AU - Norda, R

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Allergy accounts to near 0.5% of all reported transfusion adverse events. The responsibility of blood components themselves and - therefore - of blood donors is still questioned. The European Community undertook a large international survey to address the consistency and homogeneity of medical selection of blood donors with regard to the risk of allergy, and especially of transferring allergy to recipients. This short report presents the salient points of the survey, stressing that there is inconsistency in addressing the allergy question within countries or systems, with paths of improvement.

AB - Allergy accounts to near 0.5% of all reported transfusion adverse events. The responsibility of blood components themselves and - therefore - of blood donors is still questioned. The European Community undertook a large international survey to address the consistency and homogeneity of medical selection of blood donors with regard to the risk of allergy, and especially of transferring allergy to recipients. This short report presents the salient points of the survey, stressing that there is inconsistency in addressing the allergy question within countries or systems, with paths of improvement.

KW - Anti-Allergic Agents/blood

KW - Blood Donors

KW - Donor Selection/standards

KW - Drug Hypersensitivity/blood

KW - Europe/epidemiology

KW - Health Care Surveys

KW - Health Policy

KW - Humans

KW - Hypersensitivity/blood

KW - Surveys and Questionnaires

KW - Transfusion Reaction/prevention & control

U2 - 10.1016/j.tracli.2016.12.001

DO - 10.1016/j.tracli.2016.12.001

M3 - Letter

C2 - 28139398

SN - 1246-7820

VL - 24

SP - 34

EP - 35

JO - Transfusion Clinique et Biologique

JF - Transfusion Clinique et Biologique

IS - 1

ER -